ReviewFrontiers in pharmacology2023

Unleashing the efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma: factors, strategies, and ongoing trials.

Jiahui Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.